FYI: Biomarkers for Alzheimer’s Disease
Alzheimer’s disease affects approximately 3% of the Canadian population and currently has no available disease-modifying treatments. Biomarkers for this condition are increasingly playing a critical role in clinical trials for new treatments. In this talk, Dr. Steve will review current and emerging biomarkers for Alzheimer’s disease including those being investigated at the University of Alberta.
Dr. Trevor Steve
Excluded Activity Dates
More info for this activity is coming soon.
Please check back later.
|Time||1:30 PM to 3:00 PM|
|Availability||20 Spots Available|
This class will occur 1 time
during this session.